Company page
Synact Pharma Ab
Synact Pharma AB, trading under the ticker SYNACT, is a public company based in Sweden with a market capitalization of approximately 100.7 million USD. The company focuses on developing innovative therapies for inflammatory diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the pharmaceutical industry.
- Ticker
- SYNACT:OMXSTO
- Asset type
- Stock
- Market cap
- $108.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK